ArticleJCI insight2022

SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.

Bezawit A Woldemeskel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.